← Eichor
Study identifier: NCT05600140 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Viewing Strategy Training in Children With (Cerebral) Visual Impairment

Condition: Vision Disorders · Vision, Low  ·  Sponsor: Royal Dutch Visio

PhaseNA
Planned participants60
Who can joinAll sexes, 5 Years to 12 Years
Healthy volunteersYes

About this study

Viewing strategies are strategies used to process visual Information. Many children with visual impairment seem to lack systematic viewing strategies. However, it is unknown how viewing strategies differ between children with normal vision and children with (cerebral) visual impairment. In addition, viewing strategy training is often adopted in clinical practice, but till date there is no scientific evidence about effectiveness of this approach. The current project has two goals: (1) to measure viewing strategies used by children with normal vision, children with ocular visual impairment and children with CVI, and (2) to evaluate whether training viewing strategies results in more efficiënt visual Information processing.

This description comes directly from the study's public registry record.

Talk to the study team

Bianca Huurneman, PhD  ·  0(031)646944002  ·  biancahuurneman@visio.org

Always discuss trial participation with your own doctor first.

Locations (1)

Royal Dutch VisioNijmegen, NetherlandsRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05600140